FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

SWOG Trial Support (STrS) will provide critical supplemental funding

by Guest Blogger Anne F. Schott, M.D.
SWOG Deputy Chair
Hope Foundation Chair

Mar 14, 2014 - With shrinking federal grant dollars and more limited industry support, it's often difficult to piece together funding for all of the items necessary to implement a SWOG trial.

So The Hope Foundation and SWOG have established the SWOG Trial Support (STrS) program to ensure that outstanding proposals don't languish for lack of financing. STrS is designed to support trial components that need supplemental funding during patient enrollment in a SWOG study. Qualifying components may include things that are outside of the SWOG-supported norm, such as atypical requests for tissue and/or data, or provision of materials to trial sites. The award will provide up to $75,000 per year for up to two years for approved and activated SWOG trials.

Investigators may apply for STrS support at the same time they submit a clinical trial capsule for SWOG Executive Review (triage). The appropriate Committee Chair and Executive Officer should first review the STrS request for suitability.

During the Executive Review call, the STrS request will be reviewed alongside the capsule and any translational medicine components, applying two primary criteria:

  1. Impact score of the parent clinical trial
  2. Significance of the STrS component to the overall trial

Applications will receive a summary score, which will be used to determine whether or not the project is funded. For successful STrS applications, The Hope Foundation will write a letter of financial support to be submitted with the Concept to the NCTN Steering Committee, in order to increase the chances that the study will be favorably reviewed at the next step.

Of course, investigators should apply for other sources of funding as appropriate, such as R0-1, BIQSFP, or industry funding, and if successful there should be no overlap with the STrS award. STrS funding is not intended for salary support; it will support clinical trial components as the SWOG trial is enrolling patients. We expect to fund approximately one project per quarter.

STrS Award information and application forms are posted to the Research Support page on the SWOG website. If you have questions about the program, please contact me directly.


SWOG Logo Disclaimer | Copyright ©1999-2017 SWOG. All rights reserved.
Design and Hosting by nuMedia
SWOG is FISMA CertifiedSWOG is FISMA Certified